JHJintian Hu

Jintian Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jintian Hu has a total of 158 co-authors. Here are the top co-authors by number of shared publications:

  • Xueshang Su

    Department of Cosmetic Injection Center, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Beijing, China

    34 shared publications
  • Jun Zhuang

    Department of Ear Reconstruction, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    31 shared publications
  • Ziming Zhang

    Department of Cosmetic Injection Center Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

    22 shared publications
  • Qingqian Wei

    Department of Cosmetic Injection Center, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shijingshan District, Beijing, China

    17 shared publications
  • Yutong Liang

    Department of Cosmetic Injection Center, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Beijing, China

    15 shared publications
  • Liya Jiang

    Department of Cicatrix Minimally Invasive Treatment Center, Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    13 shared publications

Latest Publications

  • Open Access

    Early-onset Pulmonary Embolism After Prolonged Combined Cosmetic Breast Surgery: 2 Case Reports and a Literature Review

    by Ronghao Ouyang, Xueshang Su, Yutong Liang, Jintian Hu, Yuan Chen

    Summary: Venous thromboembolism (VTE) after aesthetic breast surgery is considered rare, and patients are often perceived as low risk. However, prolonged operative time and combined procedures may increase pulmonary embolism (PE) risk, and adjunctive liposuction may be a marker of procedural complexity and longer duration rather than an independent cause. We describe 2 women with intermediate Caprini scores who developed early-onset PE after prolonged combined cosmetic breast surgery (including adjunctive liposuction) and summarize relevant reports of thromboembolic events after aesthetic breast procedures. Procedures lasted 225 and 370 minutes, respectively. Dyspnea, chest discomfort, or palpitations occurred within 48 hours postoperatively. D-dimer was elevated, and computed tomography pulmonary angiography confirmed acute PE, including a saddle embolus in 1 patient. Therapeutic low-molecular-weight heparin followed by rivaroxaban led to clinical improvement without observed recurrence at the short-term follow-up. A focused literature review identified additional thromboembolic events after aesthetic breast surgery, most within the first postoperative week. Early-onset PE can complicate prolonged, combined cosmetic breast surgery even in patients classified as intermediate risk. Pharmacologic venous thromboembolism prophylaxis before symptom onset could not be reliably ascertained from available records. These cases support a protocolized, Caprini-informed pathway that specifies routine mechanical measures and clear indications, agent/dose, and timing for chemoprophylaxis, with explicit documentation and vigilance for early postoperative cardiopulmonary symptoms.

  • Open Access

    Long‐Term Real‐World Utilization and Continuity Patterns in Injectable Aesthetic Dermatology: A 10‐Year Single‐Center Study

    by Ronghao Ouyang, Ximeng Jia, Ziming Zhang, Yutong Liang, Benjie Li, Mengzhe Qin, Jintian Hu

    Background: Injectable aesthetic dermatology increasingly depends on repeated maintenance care, yet long‐term real‐world evidence on utilization and continuity is limited. Aims: To characterize long‐term real‐world utilization in injectable aesthetic dermatology, with attention to maintenance cadence, patient‐origin composition, and continuity of care. Methods: We retrospectively analyzed outpatient registration and billing records from one center (2015–2024). Geographic origin was an administrative address category, not measured travel burden. Annual visit‐frequency comparisons used patient‐years from 2022 to 2024; retention used index years 2015–2023, with a recent‐window analysis. Patient‐year models used standard errors clustered by patient. Time to second visit was analyzed by Kaplan–Meier and Cox methods, overall and by strictly recorded first‐visit indication proxy. Billing outcomes were exploratory. Results: Among 48 798 visits in 29 437 patients, service volume increased, especially in 2023–2024. The proportion with ≥ 2 visits/year rose from 17.6% to 27.2%, with a positive trend after age and sex adjustment. Most patient‐years in each origin group comprised one visit (75.5%–77.2%); adjusted annual count differences were small. Among 25 399 patients with resolvable origin, 29.8% had a second observed visit. Distant nonlocal origin was associated with a lower second‐visit hazard (adjusted HR 0.83, 95% CI 0.78–0.88); proportional hazards were imperfect, so time‐specific estimates are also reported. The origin‐by‐indication interaction was exploratory ( p < 0.001). Recent‐window next‐year retention was 26.0%, 21.9%, and 21.2% in Beijing, nearby nonlocal, and distant nonlocal patient‐years. Conclusion: Repeat attendance increased, although single‐visit patient‐years remained common. Geographic origin had modest associations with observed re‐engagement at this center. These descriptive findings may inform prospective evaluation of follow‐up and communication strategies.

  • Open Access

    Beyond Comorbidity: A Three-Level Clinical Framework for Endocrine–Metabolic Associations in Rosacea

    by Benjie Li, Ximeng Jia, Ronghao Ouyang, Yutong Liang, Mengzhe Qin, Tun Liu, Jintian Hu

    Rosacea has been increasingly associated with endocrine–metabolic abnormalities, but the clinical significance of these findings remains uncertain because existing studies evaluate biologically distinct outcomes, ranging from isolated biomarkers to clinically diagnosed endocrine disease. In this narrative review, we synthesize evidence across the thyroid, insulin–metabolic, gonadal and hypothalamic–pituitary–adrenal axes using a three-level framework that distinguishes biomarker-level signals, functional or contextual processes, and overt endocrine disease. Overall, the available evidence appears more coherent for functional or contextual processes than for established endocrine disorders. Insulin resistance and individual metabolic abnormalities are reported more consistently than diabetes mellitus or metabolic syndrome, thyroid-related findings remain heterogeneous, and gonadal and hypothalamic–pituitary–adrenal associations are better interpreted in terms of hormonal, vasomotor and stress-related context than persistent endocrine dysfunction. Vascular, immune-inflammatory, oxidative and neuroendocrine pathways provide biological plausibility for these associations, although causal evidence remains limited. We therefore propose that endocrine–metabolic factors may be better conceptualized as heterogeneous contextual modifiers of rosacea expression rather than as a uniform group of causal comorbidities. Current evidence does not support routine endocrine investigation solely because of rosacea; assessment should follow conventional clinical indications. Prospective, phenotype-stratified studies are needed to validate this framework and determine whether these proposed modifiers predict disease activity, phenotype or treatment response.

  • Open Access

    Recurrent Delayed Inflammatory Reaction After Dermal Filler Injection Treated With Intralesional 5-fluorouracil, Triamcinolone, and Hyaluronidase

    by Mengzhe Qin, Yutong Liang, Jiaqi Yao, Xueshang Su, Jun Zhuang, Ziming Zhang, Jintian Hu

    Summary: Infectious or biofilm-related inflammatory complications after dermal filler injection are uncommon but may be recurrent and challenging to manage. We report the case of a 44-year-old woman with recurrent erythema, tenderness, and induration in the right tear trough/infraorbital region after facial filler injection performed at an outside facility (reportedly hyaluronic acid, but the filler type was unverified). She had a normal temperature and normal routine laboratory test results. Because ultrasound suggested a small, immature fluid collection and the patient preferred conservative treatment, no incision and drainage was performed. She was treated with repeated intralesional injections of 5-fluorouracil, triamcinolone acetonide, and hyaluronidase. After multiple relapses despite prior systemic antibiotic therapy (details unavailable), repeated intralesional combination therapy achieved sustained clinical resolution. A localized contour depression was noted during follow-up. Intralesional 5-fluorouracil with triamcinolone and hyaluronidase may be a salvage option for refractory postfiller inflammatory complications with suspected infectious/biofilm involvement, particularly when conventional approaches are unsuccessful. Further studies are needed to define indications and optimal dosing.

  • Open Access

    Lower-extremity Deep Vein Thrombosis after Plastic Surgery: Clinical Characteristics and Outcomes in a Retrospective Case Series

    by Yuan Chen, Ronghao Ouyang, Hang Zhang, Jiaqi Yao, Yingzi Li, Hongli Chai, Jintian Hu

    Background: Deep vein thrombosis (DVT) is a significant complication in plastic surgery, particularly affecting the lower extremities. Understanding the associated characteristics can aid in developing effective prevention strategies. Methods: We conducted a retrospective, quality improvement–oriented case series of 5 ultrasound-confirmed symptomatic postoperative lower-extremity DVT events after plastic surgery under general anesthesia at a single institution (January 2020–May 2024). Among 39,055 general anesthesia procedures during the study period, de-identified records were reviewed for patient and procedural characteristics, prophylaxis and mobility pathways, duplex ultrasonography confirmation, management, and short-term outcomes. No non-DVT comparator cohort was extracted; analyses were descriptive and not intended for risk-factor inference. One patient with postoperative chest/back pain and transfer for suspected pulmonary embolism without in-hospital lower-extremity DVT confirmation was excluded from the final case series. Results: The 5 included cases were clinically heterogeneous and involved complex perioperative settings, including post–massive weight loss body contouring, craniofacial reconstruction with implant use, neurosurgical-related reconstruction, extensive head and neck lesion surgery, and posttraumatic facial reconstruction. All DVTs were confirmed by duplex Doppler ultrasonography, with thrombi involving the posterior tibial, peroneal, or calf muscular veins. Several cases involved prolonged procedures, reoperation for postoperative hematoma, or delayed mobilization. Postoperative anticoagulation was administered in most cases, whereas postoperative mechanical prophylaxis was not consistently documented. Conclusions: In a very low-frequency setting, this series highlights potentially actionable prevention gaps—especially postoperative mechanical prophylaxis and mobility disruptions—rather than establishing causal risk factors.

  • Cellular Remodeling of Skeletal Muscle Following Botulinum Toxin A Injection: A Single-Nucleus RNA Sequencing Study

    by Shunbing Lu, Qingqian Wei, Jun Zhuang, Xueshang Su, Yunshun Lu, Ziming Zhang, Yutong Liang, Jintian Hu

    Background Botulinum toxin type A (BoNT) is widely used in aesthetic and reconstructive surgery, yet its effects on skeletal muscle tissue at the cellular level remain incompletely defined. Methods Public single-nucleus RNA sequencing data from murine skeletal muscle (GEO: GSE267910) were reanalyzed, including control, BoNT-treated, denervation, and MuSK knockout models. Cell populations, cellular composition, and cell-type-specific transcriptional changes were systematically evaluated. Results Seven major skeletal muscle cell populations were identified. Cell-type identity was preserved across experimental conditions, with no emergence of novel lineages following BoNT injection. BoNT treatment significantly altered cellular composition, characterized by increased fibro-adipogenic progenitors and reduced myonuclei. Transcriptional responses were highly cell-type specific, with prominent changes in fibro-adipogenic progenitors and myonuclei. Compared with denervation, BoNT-induced changes showed relatively limited immune activation. Conclusions BoNT remodels skeletal muscle primarily by altering the proportion and functional state of existing cell types rather than changing cellular lineage identity, suggesting preservation of cellular lineage identity at the transcriptomic level. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

  • Seven Years of Complaints from Patients in Plastic Surgery Hospitals About Autologous Fat Transfer Procedures

    by Xueshang Su, Guyu Tan, Jun Zhuang, Yutong Liang, Ziming Zhang, Ronghao Ouyang, Bo Ding, Jintian Hu

    Background Patient complaints can provide valuable feedback on objective deficiencies in medical services. At present, there are few studies on patient complaints regarding autologous fat transfer procedures. Our findings suggest that, in real-world clinical practice, the complaint rate may exceed 5% (7.18% in the present study), underscoring the importance of further research in this area. Therefore, this study aims to analyze the complaints of patients who have undergone autologous fat transfer procedures to understand their expectations and requirements. Methods Our study conducted a statistical analysis of the chief complaints of patients who have undergone autologous fat transfer procedures. The research focused on various aspects, including the treatment items, content of complaints, types of complaints, economic compensation, and the temporal trends in the number of complaints. Results Between 2016 and 2022, a total of 571 autologous fat transfer procedures were performed, among which 41 cases involved complaints, resulting in a complaint rate of 7.18%. According to the standardized coding classification of complaints by Reader et al., the numbers of complaints in the Clinical, Management, and Relationships categories were 33 (80.49%), 6 (14.63%), and 2 (4.88%), respectively. Specifically, the subcategories included Treatment (48.78%), Safety incidents (31.71%), Bureaucracy (9.76%), Finance and billing (2.44%), Referrals (2.44%), Patient–staff dialogue (2.44%), and Staff attitudes (2.44%). The most common subcategories were Treatment (48.78%) and Safety incidents (31.71%). There were 15 cases (36.59%) where patients demanded compensation for losses and 1 case (2.44%) where patients requested free repairs or consultations. Ultimately, three patients received financial compensation. At the significance level of P = 0.05, although the number of annual complaints increased over time, the growth trend was not significant. Conclusions The complaints from patients regarding autologous fat transfer procedures are primarily of a clinical nature. Combined with the survey findings, it can be seen that quality and safety issues are the main content of complaints. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.


  • Open Access

    Impact of Different Pre‐Dilution Methods on Routine Blood Test Results: A Study With Sysmex XN ‐1000

    by Lingsong Wu, Mengzhe Qin, Zhe Xing, Fengli Jiang, Sien Zhan, Jintian Hu

    Objectives: To compare three manual pre‐dilution procedures with the automated undiluted mode on the Sysmex XN‐1000 analyzer and to identify an optimal standard operating procedure for pre‐dilution testing. Methods: A total of 60 residual EDTA‐K3 whole‐blood specimens were consecutively collected between March and May 2024 and analyzed within 2 h. Each specimen was tested in the automated undiluted mode and by three manual pre‐dilution procedures: direct mixing, dry‐tip wiping, and wet‐tip wiping. Pre‐dilution was performed at 1:7 (20 μL of blood plus 120 μL of Sysmex DCL diluent) using calibrated pipettes. All procedures were performed by one trained technician. Each method was tested in triplicate, and mean values were analyzed. White blood cell count (WBC), red blood cell count (RBC), hemoglobin (HGB), platelet count (PLT), and hematocrit (HCT) were evaluated by paired t ‐test, Pearson correlation, Passing–Bablok regression, and bias analysis against CLIA allowable total error (TEa) criteria. Results: For WBC, RBC, HGB, and PLT, no significant difference was found between any pre‐dilution method and the undiluted mode (all p > 0.05); for HCT, only Method 1 differed significantly ( p = 0.022). Passing–Bablok regression showed that the wet‐tip wiping method had the best overall agreement with the undiluted mode. TEa‐based analysis showed that only Methods 2 and 3 met allowable bias limits for all five parameters. Conclusion: The wet‐tip wiping method showed the best overall analytical performance and may be preferred for low‐volume specimens on the Sysmex XN‐1000 platform.

  • Open Access

    Local Injections of Fluorouracil for Eyelid Hordeolum

    by Mengzhe Qin, Yutong Liang, Xueshang Su, Jun Zhuang, Ziming Zhang, Hongli Chai, Jintian Hu

    Summary: Hordeolum is usually self-limited, but a subset of patients develop persistent, symptomatic induration or prefer to avoid incision and curettage in the cosmetically sensitive eyelid. Currently, treatment methods for hordeolum mainly include local warm compresses, local or systemic antibiotic therapy, and abscess incision and drainage. We describe a small case series of 4 female patients with eyelid inflammatory nodules within the hordeolum–chalazion spectrum treated with local injection of 6-fold diluted 5-fluorouracil. Clinical response and adverse events were recorded. Two patients achieved complete clinical resolution within 3 to 7 days after a single injection. One bilateral case improved rapidly after the initial injection; the right-sided lesion resolved by day 7, whereas a left-sided induration persisted despite a second injection and remained essentially unchanged at follow-up. One long-standing post–incision-and-drainage case showed marked reduction by day 2 and further improvement by day 7 but did not completely resolve. No treatment-related adverse events were observed, and no recurrence was noted in cases with complete resolution during follow-up. Local injection of 6-fold diluted 5-fluorouracil may represent a potential minimally invasive option for selected patients with persistent eyelid inflammatory nodules. Responses were variable in this small uncontrolled series; further controlled studies are warranted to clarify efficacy, optimal dosing, and safety.

  • Open Access

    Global Research Trends and Thematic Evolution in Injectable Aesthetic Medicine: A 25-year Bibliometric Analysis (2000–2025)

    by Shunbing Lu, Qingqian Wei, Jun Zhuang, Xueshang Su, Ziming Zhang, Yutong Liang, Jintian Hu

    Background: Injectable aesthetic procedures, particularly botulinum toxin and hyaluronic acid fillers, have revolutionized minimally invasive facial rejuvenation. However, the global research landscape and thematic evolution of this field remain unclear. This study presents a bibliometric and thematic evolution analysis of injectable aesthetic medicine from 2000 to 2025. Methods: Bibliographic data were retrieved from the Dimensions database and analyzed using the bibliometrix R package. A total of 1153 English-language publications were evaluated for annual trends, journal distribution, keyword networks, and thematic transitions across 3 time periods (2000–2009, 2010–2016, and 2017–2025). Results: Global publication output showed exponential growth, particularly after 2017, reflecting increasing clinical and academic interest in minimally invasive rejuvenation. The most frequent keywords—hyaluronic acid, botulinum toxin, complications, ultrasound, and artificial intelligence (AI)—highlighted the transition from material-focused studies to imaging- and technology-assisted precision aesthetics. Six major research clusters were identified, covering safety, anatomy, materials and technology, patient outcomes, ultrasound guidance, and AI-assisted analysis. Aesthetic Surgery Journal , Plastic and Reconstructive Surgery , and Dermatologic Surgery were the most productive sources. Conclusions: Over the past 25 years, injectable aesthetic research has evolved from empirical artistry toward evidence-based, technology-driven practice. Emerging trends emphasize vascular safety, ultrasound-guided injection, and AI-enhanced symmetry assessment. Future research should prioritize multicenter collaboration, standardized outcome reporting, and translational integration of clinical, material, and computational sciences to advance individualized, intelligent aesthetic medicine.